콘텐츠로 건너뛰기
주식/증권 ➡️ 중립

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?

요약

The biotech's innovative platform could pay off.